JAZZ
NASDAQ
IE
Jazz Pharmaceuticals plc - Ordinary Shares
$186.95
▼ $-1.32
(-0.70%)
Vol 696K
7
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$10.3B
ROE
-9.3%
Margin
-8.9%
D/E
135.42
Beta
0.27
52W
$95–$183
Wall Street Consensus
23 analysts · Apr 20268
Strong Buy
13
Buy
2
Hold
0
Sell
0
Strong Sell
91.3%
Buy Rating
Price Chart
Similar Stocks
Earnings
Beat rate: 25.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Dec 2025 | $6.65 | $6.64 | $-0.01 |
| Sep 2025 | $6.04 | $8.13 | +$2.09 |
| Jun 2025 | $-7.76 | $-8.25 | $-0.49 |
| Mar 2025 | $4.75 | $1.68 | $-3.07 |
Quarterly Revenue & Earnings
| Quarter | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|---|
| Revenue | — | $1.1B | $897.8M | $1.0B | $1.1B | $1.2B |
| Net Income | — | $191.1M | -$92.5M | -$718.5M | $251.4M | $203.5M |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -10.0% | -10.0% | -10.0% | -10.0% | -9.2% | -9.2% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | -68.7% | -9.9% | -9.9% | -9.9% | -8.9% | -8.9% |
| Gross Margin | 88.9% | 88.7% | 88.7% | 88.7% | 88.5% | 88.5% |
| D/E Ratio | 144.73 | 144.73 | 144.73 | 144.73 | 135.42 | 135.42 |
| Current Ratio | 1.62 | 1.62 | 1.62 | 1.62 | 1.65 | 1.65 |
Key Ratios
ROA (TTM)
-3.2%
P/S (TTM)
2.48
P/B
1.8
EPS (TTM)
$-6.07
CF/Share
$10.05
Rev Growth 3Y
+9.6%
52W High
$182.99
52W Low
$95.49
$95.49
52-Week Range
$182.99
Financial Health
Free Cash Flow
$292.3M
Net Debt
$4.0B
Cash
$1.4B
Total Debt
$5.4B
As of Dec 31, 2025
How does JAZZ compare to Pharmaceuticals peers?
Peer group: Large-cap Pharmaceuticals ($10B+) · 7 companies
JAZZ valuation vs Pharmaceuticals peers
P/E ratio
—
▼
0%
below
peers
(18.2)
vs Peers
vs Industry
Overvalued
P/S ratio
2.5
▼
21%
below
peers
(3.2)
vs Peers
vs Industry
Pricier
P/B ratio
1.8
▼
9%
below
peers
(2.0)
vs Peers
vs Industry
Fair value
Div yield
—
▼
0%
below
peers
(3.1%)
vs Peers
vs Industry
In line
JAZZ profitability vs Pharmaceuticals peers
ROE
-9.3%
▼
180%
below
peers
(11.6%)
vs Peers
vs Industry
Weak
Net margin
-8.9%
▼
148%
below
peers
(18.4%)
vs Peers
vs Industry
Weak
Gross margin
88.5%
▲
22%
above
peers
(72.3%)
vs Peers
vs Industry
Below avg
ROA
-3.2%
▼
177%
below
peers
(4.2%)
vs Peers
vs Industry
Weak
JAZZ financial health vs Pharmaceuticals peers
D/E ratio
135.4
▲
90%
above
peers
(71.1)
vs Peers
vs Industry
High debt
Current ratio
1.7
▲
0%
above
peers
(1.7)
vs Peers
vs Industry
In line
Beta
0.3
▼
69%
below
peers
(0.9)
vs Peers
vs Industry
More volatile
JAZZ fundamentals radar
JAZZ
Peer median
Industry
JAZZ profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
JAZZ vs peers: key metrics
Insider Activity
NeutralBuys
0
Sells
0
CARR PATRICIA
Officer · Mar 09
1287 shs
COZADD BRUCE C
Director · Mar 03
6000 shs
RIEDEL NORBERT G
Director · Feb 27
3415 shs
CARR PATRICIA
Officer · Feb 27
2370 shs
RIEDEL NORBERT G
Director · Feb 27
3415 shs
PATIL NEENA M
Officer · Feb 26
51000 shs
HENDERSON MARY ELIZABETH
Officer · Feb 26
5343 shs
PATIL NEENA M
Officer · Feb 26
55600 shs
CARR PATRICIA
Officer · Feb 26
2223 shs
PEARCE SAMANTHA
Officer · Feb 26
9782 shs
Last 90 days
Top Holders
Top 5: 31.05%Vanguard Group Inc
9.61%
$1.1B
Blackrock Inc.
8.86%
$1.0B
Capital World Investors
4.33%
$491.4M
Dimensional Fund Advisors LP
4.26%
$483.4M
LSV Asset Management
3.99%
$452.6M
As of Dec 31, 2025
Latest News
No related news yet